Mark Lawler: Consistency of cancer policy is associated with better outcomes

Mark Lawler shared a post by Dr. Liz O’Riordan on X/Twitter:

“Have been banging this drum for a while including in evidence I gave to House of Commons Health and Social Care Future Cancer Inquiry. Spread the word Consistency of cancer policy is associated with better outcomes The Lancet Oncology. Lets hope powers that be listen,before its too late.”

Quoting Dr. Liz O’Riordan’s post:

“Why does England not have a cancer plan?
When 1 in 2 of us could get cancer if we live til we’re 80, surely we need policies in place?
Our outcomes are severely lagging behind many European countries who have policies and plans in place.
Why?”

Source: Mark Lawler/X and Dr. Liz O’Riordan/X

Professor Mark Lawler holds the positions of Associate Pro-Vice-Chancellor, Professor of Digital Health, and Chair in Translational Cancer Genomics at the Faculty of Medicine, Health and Life Sciences at Queen’s University Belfast (QUB).

He serves on the Board of the European Alliance for Personalised Medicine (EAPM) and was instrumental in developing EAPM’s research strategy.

Additionally, he is a member of the Scientific Advisory Board of the European Cancer Patient Coalition and the Strategic Advisory Board of Genomics England.

His expertise includes genetics, precision medicine, health data, COVID-19, cancer, and patient and public involvement in research.

Liz O’Riordan is a breast surgeon, motivational speaker, writer, cancer patient, and advocate Stevefrom the UK, who blogs about her experiences as a doctor and patient.

She has written articles for the Huffington Post, Macmillan, The Pool, and Grazia. Her TEDx talk is called ‘Jar of Joy’.

She is the co-author of the book “The Complete Guide to Breast Cancer” (2018), and recently released her memoir “Under the Knife” (2023).

In 2016 Dr. O’Riordan was nominated for the “Woman of the Year” award. In 2017, the UK Blog Awards highly commended her for her blog “Breast Surgeon with Breast Cancer”. In the same year, she was nominated as one of Medscape’s best physicians of the year.